September 15, 2022
Live Patient Safety Continuing Education Webinar Hosted by FDA’s Division of Drug Information for Students and Health Care Professionals
The National Association of Boards of Pharmacy (NABP) is pleased to announce that the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Division of Drug Information is presenting a series of live continuing education (CE) webinars designed to aid health care professionals and future clinicians to provide better patient care by knowing how to find relevant FDA regulatory information that will improve drug safety. The webinars are presented by FDA staff.
FDA Drug Topics:
Devolopment and US Regulation of Preventative Vaccines
Date: Tuesday, September 27, 2022
Time: 1 PM EDT | 10 AM PDT
Duration: 60 minutes
This webinar will provide a general overview of the development of and federal regulations for vaccines in the United States. It will also discuss key statutes that grants FDA authority to regulate vaccines, precipitating historical events, and current regulatory requirements for vaccine licensure and marketing approval. The basic vaccine development process and key regulatory milestones will also be covered during the webinar.
After signing up for this webinar, registrants will receive a calendar invitation with details on how to join the online meeting. Instructions on how to claim CE credit and obtain a copy of the presentation slides will be emailed to participants the next business day after the webinar.
Please note that the webinar capacity is 1,500 participants; registration does not guarantee entry. Those who are unable to join the meeting may either view the webinar recording that will be posted online or participate in the home study CE course that will be available in a few weeks.
The FDA CDER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
NABP encourages you to forward this information to your staff and to health care professionals in your state. For more information and to learn about future webinars, please visit www.fda.gov/DDIWebinars.